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Introduction: 
 
Despite the existence of safe and effective vaccines, measles and rubella present a 
major public health problem in many developing countries, disproportionally affecting 
low-income populations.1-3 Indeed, measles and rubella remain two of the leading causes 
of death and congenital defects in children worldwide.4-6 In 2008, an estimated 10 million 
new cases and 164,000 deaths were reported from measles alone.3 During the same time 
period, the United Nations International Children's Emergency Fund (UNICEF) reported 
an estimated 110,000 cases of Congenital Rubella Syndrome (CRS) in developing 
countries, with the continent of Africa shouldering 38% of the disease burden.7  
Measles is a highly infectious viral disease caused by the measles virus.  The 
infection is transmitted person-to-person by contact with contaminated droplets in the air. 
6,8,9 The symptoms of the diseases are characterized by conjunctivitis, coryza, malaise, 
and a generalized maculopapular rash.6,8,9 The diseases has a case fatality rate of 10%, 
which is largely due to an increased susceptibility of measles-infected persons 
contracting secondary bacterial infections.1,3,9, Similar to the transmission and symptoms 
of measles, rubella is by comparison less severe. Caused by the rubella virus, the rubella 
diseases usually presents as a mild, febrile rash illness in children and adults.4 
Importantly, when a woman is infected with rubella early in her pregnancy, particularly 
during the first 16 weeks, the virus can result in miscarriage, fetal death, or an infant born 
with CRS.4 
In 1999, a reported 61% of global deaths from measles occurred in Sub-Saharan 
Africa.10 This high percentage prompted many countries in the region to launch 
accelerated measles control programs to meet the 2005 global target of halving the 
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number of measles-related deaths.10 As a result, impressive gains in achieving 75% of the 
global reduction in measles deaths occurred in Africa.10 The great strides made in 
reducing measles-related deaths were achieved by institutionalizing routine immunization 
programs through the World Health Organization’s Expanded Program on Immunization 
(EPI), which is a disease prevention activity aimed at reducing morbidity and mortality 
from childhood diseases preventable by immunization.10-12 WHO member countries 
administer EPI services as part of their routine immunization schedule against childhood 
killer diseases such as Tuberculosis, Polio, Whooping cough, measles and Tetanus. 
Vaccines against these target diseases are known as the eight EPI vaccines which 
includes: one dose of Bacillus Calmette-Guerin (BCG), three doses of DPT (against 
diphtheria, pertussis, and tetanus), three doses of oral polio vaccine, and one dose of 
measles vaccine.11,13,14 WHO recommends that these eight vaccines be given routinely to 
all children from birth through 12 months.13,14 
A safe and effective rubella-containing vaccine (RCVs) has been available since 
the 1960s.4,15 In developed nations, RCVs were promptly introduced in national 
immunization schedules, however, until the 1990s, the vaccine was not available in 
developing nations due to (1) the cost of the new vaccine and (2) insufficient 
documentation of the burden caused by rubella virus in these parts of the world.4 Rubella 
and RCS were vastly underreported in developing countries because of the difficulties 
associated with surveillance.4 
A cost-benefit analysis of introducing RCV in national immunization schedules 
has shown such an intervention to be cost-effective, contrary to past concerns.4,16 
According to S.E. Reef et al, studies conducted in Barbados and Guyana revealed that the 
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lifetime cost of treating a single CRS case was estimated to be $50,000 in Barbados and 
$64,000 in Guyana.4 On the other hand, the rubella vaccine is highly affordable; the same 
report by S.E. Reef et al shows that the incremental costs of incorporating RCV in 
measles-rubella (MR) and measles-mumps-rubella (MMR) vaccines using a 10-dose vial 
are $0.31 and $0.70–$1.37 per dose, respectively.4  
In the past, documenting the extent of rubella and CRS were particularly 
challenging because of the difficulties of diagnosis and reporting in settings with limited 
medical resources.4,16 However, through progress made in medical technology, there has 
been great improvement in disease surveillance systems.4 This has prompted an increase 
in the case reporting of rubella to WHO by member states. For example, from 2000-2009, 
the reported rubella cases in the African region increased from 865 to 17,388, and 
number of reporting countries increased from 7 to 38.4 In recent decades, the progress 
made in better identifying cases prompted many member states to introduce RCV in 
national immunization schedules. Therefore, as of 2009, 130 of 193 member states had 
introduced RCV, including two countries from the WHO African region.4,16 
The low introduction rate of RCVs in Africa is due to the lack of establishing 
rubella elimination, control, or prevention goals in the region.15,16 From 2000-2009, this 
hampered African countries from addressing the 20-fold increase in rubella cases.4,15 
Through EPI, most African countries already administer measles-containing 
vaccine (MCV) as part of their national routine immunization program.11 Thus, switching 
from a single measles antigen to a combined MR or MMR vaccine is not only cost 
effective, but presents an opportunity to address the rising rates of rubella and CRS.15 
Recently, the feasibility of switching from MCV to MR has been made possible through 
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funding from the Global Alliance for Vaccines and Immunization.  For funding 
consideration, GAVI-eligible countries – the majority of which are found in sub-Saharan 
Africa – must meet one of two requirements: (1) maintain high immunization coverage of 
the eight EPI vaccines, and (2) achieve and sustain a >80% coverage of MCV. 17 
In an attempt to meet the requirement set by GAVI, 16 African countries have 
sustained MCV coverage of >80% (i.e., Algeria, Botswana, Burundi, Cape Verde, 
Eritrea, Gambia, Ghana, Lesotho, Malawi, Rwanda, Sao Tome, Sudan, Swaziland, Togo, 
Tanzania, and Zambia),4 of which only Rwanda has introduced RCV into its 
immunization schedule as of 2013.18  
Rwanda and Uganda  
Geographically, both Rwanda and Uganda are neighboring countries located in 
East-Central Africa. Demographically, both countries consist of relatively young 
individuals, where 42.3% and 48.9% of the population are ages 0-14, respectively.19 The 
total median age in Rwanda is 18.7 years and 15.5 years in Uganda.19 Birth rates in 
Rwanda and Uganda are fairly close: 2013 census estimates were 35.49 births/1,000 
populations for Rwanda and 44.5 births/1,000 populations for Uganda.19 As of 2013, the 
total infant mortality rate was 61.03 deaths/1,000 live births for Rwanda, and 62.47 
deaths/1,000 live births for Uganda.19 According to the 2011 census for both Rwanda and 
Uganda, health expenditures were 10.8% and 9.5% of GDP, respectively, and education 
expenditures were 4.8% and 3.3% of GDP, respectively.19 Both countries are also 
comparable on the basis of economy and government type: they both are republics and 
according to the 2012 census, GDP per capita for both Rwanda and Uganda were 1,500 
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and 1,400 US dollars, respectively.19 A map of both countries is found in Figure 1, and 
characteristics of both countries are summarized in Figure 2.  
 
Objective: 
Due to the paucity of research evaluating the slow introduction of RCV in Sub-
Saharan Africa, this study employs the requirements set by GAVI to examine causes for 
low uptake of MCV in Africa and the subsequent introduction of the vaccine by only one 
country given the established burden of the disease in the region. The assessment will be 
conducted by evaluating EPI services and program performance of Rwanda and Uganda 
in providing all eight EPI vaccines and maintaining high coverage rates. Comparing 
Rwanda to Uganda, a country that has successfully introduced the combined measles-
rubella vaccine to a country that has not, allows for a better understanding of areas 
needing improvement when introducing this positive public health practice in African 
countries.  Due to the lack of direct measures for country-level health governance, the 
study uses population characteristics as key indicators to explore how Rwanda has been 
able to meet GAVI requirements and introduce the vaccine in comparison to why Uganda 
has not been able to do so.  
By conducting a comparison case control-study of Rwanda and Uganda, this 
research seeks to (1) determine which population characteristic has the most influence on 
vaccination uptake (e.g. child age, parents education and residence); (2) test routine 
immunization coverage rates to evaluate the effectiveness of EPI services of both 
countries in delivering all eight vaccines; and (3) assess the overall MCV coverage rate 
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for both countries to analyze whether or not they meet the 80% coverage rate 
requirement.  
Methods 
Data Source & Study Sample: 
Data for both Rwanda and Uganda used in this study were obtained from the 2010 
Rwanda Demographic and Health Survey (RDHS) and the 2011 Uganda Demographic 
and Health Survey (UDHS).  This data source was deemed appropriate for comparison of 
immunization data because it is nationally-representative and accurately reflects the 
population.  The data were collected using a stratified two-stage cluster sampling 
procedure. The initial sampling stage involved selecting 492 clusters for Rwanda and 404 
clusters for Uganda; the second sampling stage involved systematically selecting 
households from the already selected clusters.13,14 This resulted in a probability sample of 
12,792 households for Rwanda and 10,086 for Uganda from which data were collected 
by face-to-face interviews from 13,671 (Rwanda) and 9,247 (Uganda) women aged 15 to 
49 years. Interviewed mothers from both countries contributed information on child 
immunization histories for a total of 16,880 children born within five years prior to the 
survey: 9002 (Rwanda) and 7878 (Uganda).13,14  
The survey collected in-depth demographic, socioeconomic information, as well 
as information on birth histories and immunization details of children.13,14 Information on 
vaccination coverage was obtained via two methods – from child health cards and from 
mothers’ verbal reports if the health card was not available.13,14 This publicly available 
dataset for the Measure DHS project was produced by ORC Macro through the US 
Agency for International Development (USAID) funding.13,14  
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Measures: 
In order to obtain information on vaccination coverage of children aged 0 to 59 
months, the present study merged three different dataset survey files on the basis of 
matching variables: household, individual, and children. The children’s survey dataset 
was the primary file from which the unit of analysis was established, while both 
household and individual surveys were appended to the children’s survey.   
Outcome variable 
The outcome variable was the likelihood of a child between 0 to 59 months old 
having received all eight recommend vaccines (yes/no). Full immunization was coded as 
1 if the child received all 8 vaccines, and 0 if the child received 0-7 of the vaccines. For a 
child to be classified as being completely vaccinated with each vaccine, they had to 
receive all vaccine doses. For BCG and Measles, vaccine completion, 1, was denoted as 
child receiving BCG and Measles and 0 for otherwise. For a child to be coded as having 
received DPT, they had to have completed all three doses, anything less than the required 
three doses was denoted as “not receiving DPT.” Likewise, for the Polio vaccine, the 
completion of all three doses was denoted as “receiving the vaccine” and anything less 
than the required three doses was denoted as “not receiving Polio vaccine.”  
Predictor variables  
Intrapersonal-level factors. Two individual child-level variables of interest were 
examined: (1) sex of child, assessed as male and female; and (2) age of child in months, 
grouped as: <12 months, 12-23 months, 24-35 months, 36-47 months, and 48-59 months.  
Interpersonal-level factors. Four parental and household-level variables of 
interest were examined. The first variable “Parents’ education” was created by appending 
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mother and father education variables; “parents’ education” level was determined by the 
highest level of education attained by either mother or father: no education (reference 
category), primary education, secondary education and higher. The second variable 
“parents’ age” was created by appending the mother and father’s age, and grouped as: 
<20 years, 20-34 years, and 35-49 years. The “parents’ age” group was determined by the 
highest age of either mother or father. The third variable “insurance coverage” was 
grouped as “insured” and “uninsured.” Lastly, the fourth variable, “household economic 
status” was created using the DHS wealth index as a proxy with quintiles ranging from 
poorest (reference category) to richest.13,14 
Community-level factor. Geographic residence was the only community-level 
variable of interest and was categorized as: “urban” or “rural.”  
Statistical Analysis: 
The study analyses were conducted using IBM SPSS Statistics software (version 
21.0).  Descriptive statistics reported in Table 1 show the distribution of key 
characteristics among respondents. Chi-square (X2) analyses (Table 2) were used to 
describe the association between individual predictor variables and full immunization 
status. A stepwise logistic regression model (Table 3) was applied to identify the subset 
of predictor variables with the strongest relationship to a child’s full immunization status. 
For both bivariate and regression analyses, probability values less than 0.01 were 
considered significant. Lastly, a 2x2 table (Table 4) was used to assess the uptake of 
MCV in both Rwanda and Uganda.  
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Ethics: 
The Institutional Review Board at the University of Kentucky waived review of this 
study because it was a secondary data analysis of an existing survey data that had all 
identifying information removed.  
Results 
 
Of the 16,880 children aged 0-59 months analyzed, 9002 children were Rwandese 
and 7878 children were Ugandan (Table 1).  In Rwanda, 76% of children between 0 and 
59 months were fully immunized, compared to 43% in Uganda. The distribution of males 
and females was fairly even between both countries. However, Rwanda had slightly more 
males (50.9%) then girls (49.1%).  Overall, there were more parents aged 20 – 34 years, 
57.7% in Rwanda and 54.1% in Uganda, compared to the < 20 and 35 – 49 age groups. 
Those aged <20-years was 0.6% for Rwanda and 1.1% for Uganda. The second largest 
age group, those aged 35 – 39 years, were 41.6% in Rwanda and 45% in Uganda.   
 In Rwanda, far more parents had completed primary education (73.1%) than had 
no education (13.4%) and secondary or higher (13.5%). In Uganda, more parents had 
completed primary (52.3%) and secondary education or higher (37.2%) in comparison to 
having had no education (10.5%).  More children in both Rwanda (23.1%) and Uganda 
(26%) belonged to the poorest quintile of households rather than the richest quintile of 
households. More children resided in rural than urban areas, with 86.4% of children in 
Rwanda in rural areas and 78.6% in Uganda. In Rwanda, 73.3% of the surveyed 
population had insurance coverage as compared to 58.5% in Uganda.   
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This study sought to carry out comparison analysis between Rwanda and Uganda. 
Due to a low respondent rate in Uganda for “insurance coverage,” this predictive variable 
was excluded from the bivariate and multivariate analyses of both countries.  
Overall, five variables were significantly associated with a child’s uptake of all 
vaccines in unadjusted bivariate analyses (p-value < .01): child’s age, residence, 
household income, parents’ age, and parents’ education (Table 2). The association 
between parents’ education with child’s vaccine uptake was only significant for Uganda 
and not Rwanda (p-value = .100).  In both countries, the sex of the child was not 
statistically associated with vaccination uptake (p-value = .026 for Rwanda; p-value = 
.774 for Uganda). However, more boys in Rwanda were fully immunized (52%) than 
girls (49%). On the contrary, in Uganda 51% of girls were fully immunized as compared 
to boys at 50%.  
The following variables were statistically associated with vaccination uptake in 
multivariable analysis: residence, household income, child’s sex, parents’ age, and 
education.  
Within the Rwanda sample (Table 3), four factors were positively associated with 
a child’s uptake of all vaccines in unadjusted bivariate analyses (p-value < 0.01): child’s 
age, residence, household income, and parents’ age. However, with all factors controlled 
for in the fully adjusted logistic model, parents’ aged 20-34 years (AOR=3.26; 99% CI: 
1.12 – 9.50), and children living in richer (fourth wealth index quintile) households 
(AOR=1.47; 99% CI: 1.00 – 2.16) were the only factors found to be significant and 
positive determinants of a child’s vaccination uptake. While child’s sex and residence 
were found to be significant, specifically being a female (AOR= 0.74; 99% CI: 0.58 - 
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0.94) and residing in rural area (AOR= 0.64; 99% CI: 0.41 – 1.01) negatively determined 
a child’s vaccination uptake.  
Within the Uganda sample (Table 3), five factors were positively associated with 
a child’s uptake of all vaccines in unadjusted bivariate analyses (p-value < 0.01): child’s 
age, residence, household income, parents’ age, and parents’ education. In the fully 
adjusted logistic model, when holding all variables constant, living in a rural area was a 
significant and negative determinant of a child’s vaccination uptake (OR= 0.68; 99% CI: 
.46 – 1.00), while having parents with secondary education or higher was a significant 
and positive determinant of a child’s vaccination uptake (OR= 1.787; 99% CI: 1.027 – 
3.109).  
The multiple logistic regression model of the socio-demographic characteristics 
accounted for a reasonable amount (Nagelkerke R2 =0.45 for Rwanda; Nagelkerke R2 
=0.21 for Uganda) of predictability related to vaccination uptake.  
Table 4, shows the weighted percentage and frequency of fully vaccinated 
children by MCV coverage rate for both Rwanda and Uganda. Of the total fully 
vaccinated children, 82.1% (6956) of children in Rwanda received MCV, compared to 
68.4% (5017) in Uganda.  
Discussion:  
 
Main Findings:  
 
The present study attempts to show which population characteristic has the most 
influence on vaccination uptake in a country with high immunization coverage (Rwanda) 
and one with low immunization coverage (Uganda).  Results indicate that all three levels 
– intrapersonal (child’s gender and age), interpersonal (parents’ age and education, and 
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household economic status), and community (residence type) – are important in 
explaining differences in immunization status among children in the study. On average, 
the study found that 76% of children in Rwanda were fully immunized, compared to 43% 
in Uganda. These numbers were inconsistent with literature, the final 2010 RDHS 
reported 90% coverage and the 2011 UDHS reported 52% coverage.13,14 Discrepancies in 
results is because past studies coded full immunization as 1 if the child received all 8 
vaccines and 0 if the child received 0 vaccines.13,14 Children who received 1-7 of the 
vaccines were excluded. However, in this study, we included all children and categorized 
them as 1, for receiving all 8 vaccines, and 0, for receiving 0-7 of the vaccines.  
Prior literature highlights the importance of both paternal and maternal education 
in predicting a child’s full immunization uptake.3,20,21 Education is said to be an important 
predictor in changing attitudes and beliefs. Parents that are educated have more control 
over resources and tend to be more autonomous, and thus practice better healthcare 
seeking behaviors. 21,22 Findings for the Uganda sample were consistent with previous 
literature. Specifically, the current study found that education was positively associated 
with a child’s uptake of all eight vaccines, and having parents with secondary education 
or higher increased this odd by 0.30 in comparison to children whose parents only had 
primary education.  However, in the Rwanda case, findings were inconsistent with 
previous studies.20,21 Parental education was not significantly associated with full 
immunization but the odds of full immunization increased with higher educational 
attainment. 
An urban and rural area discrepancy in immunization coverage was found in both 
Rwanda and Uganda. In both countries, children residing in rural areas were at 
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significantly higher odds of receiving full immunization than children residing in urban 
areas. These findings are in agreement with previous studies attributing residential 
disparities to inaccessibility of health care services.22 Conditions such as long distance 
from health centers, poor road networks, poor social infrastructure, and area economic 
depravity all contributed to making children in those areas inaccessible to vaccination 
officers.20,22,23 Consequently, most of these children only get vaccinated during national 
immunization days.  
The overall household economic status for both countries was not significant in 
determining full immunization status. Which, according to Edward Bbaale, is to be 
expected because immunization is universal in both Rwanda and Uganda.22 However, in 
the case of Rwanda, children from the richer wealth index were found to have 
significantly higher odds of being fully immunized than those in the lower wealth index. 
This is attributed to the propensity that parents from higher wealth index have more 
access to information, in seeking medical care, and in having their children 
immunized.20,22 Although not significant in determining uptake of vaccination, children 
from the richest households had a much greater odds of being fully immunized than that 
those of lower household economic status (AOR=1.243). However, there was a 
discrepancy between the richer and richest households. Instead of seeing an increase from 
one to the other, the reverse was observed. The adjusted odds of being fully immunized 
decreased by 0.23 from richer to richest households. This decrease is attributed to the 
difference in sample size between the two groups.  
The current study showed that in Rwanda, the overall parents’ age was significant 
in determining vaccination uptake. However, this was not true for Uganda. The 20-34 
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year old age group was significantly associated with full immunization coverage, whereas 
the 35-49 year old age group was not. However, the odds of full immunization were high 
for both these groups. Because a larger sample of parents were aged between 20-34 years 
of age compared to 35-49 years, the odds of being fully vaccinated decreased by one fold 
between these two groups. In Uganda, there was an observed one-fold increase of 
immunization coverage from the 20-34 to the 35-49 age group. Edward Bbaale found that 
the association between parents’ age and vaccination uptake was attributed to experience 
accumulated over time. As parents witness fatalities linked to children not receiving 
immunization, their perceptions change. 22,23 
In examining the discrepancy in the distribution of vaccination coverage by age 
and sex of the child, our study revealed a significant difference for both these variables in 
Rwanda but not Uganda.  Due to the nature of the study, significance should not be 
expected in the sex and age of child when determining full immunization. However, in 
Rwanda, sex was significantly associated with vaccination uptake as boys had higher 
odds than girls of being fully immunized. This finding was consistent with a study by 
Joyce Lyimo looking at uptake of measles vaccine services in Tanzania. Female children 
in this study were found to be less likely to receive complete immunization and more 
likely to remain in the non-immunization than boys.21 Although not significant, in our 
study, boys in Uganda were also found to have higher odds of being fully immunized 
than were girls. The variation in sex could be attributed to the importance that is placed 
on male children compared to female children. 
The inherent nature of the present study makes age significant across all 
categories; however, this study was interested in examining the distribution of 
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vaccination coverage between the different categories to determine how consistent a 
country was in meeting the WHO recommended restriction on vaccination age 
administration. It was seen that in Rwanda, children aged 12-23 months had higher odds 
of being fully immunized, thus adhering to WHO recommendation, than did children in 
Uganda within the same age category. According to Edward Bbaale, this difference could 
be attributed to parents’ lack of knowledge concerning the right vaccine dosage and age 
of administration; some children may receive one dose or two but not the full course.22 
Additional reasons for not receiving all vaccines could be linked to availability, personal 
beliefs, and circumstances out of parents’ control such as political instability, war, and 
displacement.22 
The assessment of measles containing vaccine (MCV) coverage rate revealed a 
discrepancy between the countries. Overall, the results from the study showed that in 
Uganda, of the 43% fully immunized children, only 68% of them received MCV. This 
does not meet GAVI requirement of 80% coverage needed for RCV funding 
consideration. Unlike Uganda, the study showed that Rwanda met the 80% MCV 
coverage requirement, thus explaining why they have been able to introduced RCV in 
their national immunization schedule. According to the researched literature, reasons for 
the low uptake of MCV in Uganda could be attributed to the importance parents place on 
vaccines.21 With limited knowledge of the purpose of immunization, they might choose 
which vaccines they want their children to receive, while depriving them of other 
essential inoculations.21 
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Strength and Limitations: 
 
The strength of the study is in its use of a large, nationally representative data 
survey with enhanced generalizability. Also, this is the first research to compare 
immunization measures of both these countries.  
However, the study results are limited by the absence of direct measures for 
country-level health governance of immunization systems and services in relation to child 
immunization. Instead, the study attempts to measure this indicator by using population 
characteristics in relation to the uptake of all eight vaccines. The use of population 
characteristics might not give a full picture of a country’s governmental ability to 
formulate and implement sound policies and regulations that permit and promote 
effective immunization activities.  
This study is also limited by recall bias. Since data were collected retrospectively 
over the past five years, in the case of missing health cards, mothers may not have 
correctly recalled all the vaccines the child might have received.  In addition, the study is 
limited to restrictions placed on immunization coverage groups (having received all eight 
vaccines), and those not covered (receiving 0-7 vaccines). This categorization, affected 
the distribution of the coverage rates for both countries, by decreasing the rate of full 
immunization. Lastly, the findings of the study are limited to only Rwanda and Uganda 
and cannot be generalized to other African countries.  
Conclusion:  
 
Uganda: 
Given that our variables for the Uganda sample accounted for low predictability 
of vaccination uptake, denoted by the R2 of .21, we have reasons to believe that other 
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variables other than the one included in our regression model seems to be influencing 
uptake. Additionally, results of the study suggest that the health infrastructure of the 
country is comparatively deficient in achieving high immunization coverage rates. As 
mentioned in the discussion, factors influencing the low immunization uptake in this 
region are negatively affecting the efficacy of EPI services. Which, according to 
Ssewanyan et al, is linked to challenges with inadequate medical staffs, insufficient 
funding resulting in supplies stock-outs, scarcity of service provisions, and a disgruntled 
workforce.24   
 To address the shortcomings of EPI services and programs performance, it’s 
imperative to first conduct a process and outcome evaluation of current health sector 
reforms. Understanding where breaches in policy implementations occurs, will provide 
crucial information about areas in the implementation process requiring further 
improvement. To address the challenges of scarcity highlighted by Ssewanyan et al, 
governmental leadership is required to increase salaries of the medical staff and increase 
expenditure on drugs.22,24,25 In combination with the evaluations of health sector reforms, 
these efforts will help boost the quality of services provided by health facilities.  
Secondly, given that our results highlighted residential disparities, efforts are 
needed from the government to strengthen vaccination programs in rural areas. These 
efforts could focus on improving roads and transportation, addressing some of the 
impediments vaccination officers experience in reaching children living in these 
communities.22 Since previous research found that low vaccination uptake in rural 
communities in Uganda are linked to challenges with inadequate medical staff, 
insufficient funding in rural health centers and scarcity of provisions, the present study 
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recommends that the Ministry of Health (MOH) focus its efforts in the financing of rural 
health centers, to hire more qualified medical personnel to fill vacancies in rural areas, 
and lastly, to carry out more vaccination programs in rural communities in order to 
educate and improve patient care.  
For the last recommendation, the present study stresses the importance of targeted 
information campaigns. We recommend that the Health Communication Department at 
the Ministry of Health make use of media sources such as the radio, televisions, banners 
and newspapers to sensitize the general population on the importance of vaccines and the 
importance of children receiving all vaccine doses.  
The second portion of the targeted information campaign should be geared toward 
one-on-one transmission of information, where (1) trained community health workers 
could provide prenatal care to mothers in rural communities and take advantage of this 
window of opportunity to stress the importance of timely immunization of babies (12-23 
months), and (2) the Ministry of Education in collaboration with Ministry of Health, need 
to incorporate health knowledge and education into primary school curriculum in order to 
educate future mothers and fathers.  
Rwanda: 
Rwanda, on the other hand, seems to have an adequate EPI program, and is doing 
a reasonable job of getting children vaccinated at appropriate ages and completing 
vaccination courses. However, results from our regression model highlighted residential 
and gender disparities related to vaccination uptake.  Thus, our recommendation is for the 
Ministry of Health to implement Mobil Health Clinics in rural communities in order to 
increase access to services. Efforts are also needed from the Rwandan government to 
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enhance vaccination uptake of children residing in rural areas. Similar to 
recommendations made for Uganda, a way to address the issue is to improve roads and 
transportation infrastructures to make villages more accessible to vaccination officers.22  
In addressing the issue of gender disparity, government efforts are need to 
institute programs and policies that incorporate gender into programing in order to 
eliminate gender-disparities in vaccination uptake.  
Future studies could address limitations of the present study by using more direct 
measures of health governance to examine how political leadership influences 
vaccination coverage rates in both countries. Future studies could also address the issue 
of immunization coverage groups: fully vaccinated (received all 8 vaccines), the in-
betweens (received 1-7 vaccines), and those not vaccinated (received 0 vaccines). To 
better understand causes for low vaccination uptake, it could help to examine individual 
doses to survey vaccines children are not receiving. Doing this, will allow for more 
targeted immunization campaigns to increase the uptake of these vaccines.  
Summary:  
Overall, this study provides insights into factors influencing immunization 
coverage of children in both Rwanda and Uganda. The findings of the study have 
significant public health implications for Uganda, as it lags behind in introducing RCV in 
its national immunization schedule, and Rwanda in achieving and sustaining high 
coverage rates of RCV.  
 This study found that population characteristics – intrapersonal, interpersonal, 
and community factors – were significantly associated with vaccination uptake. Using the 
coverage rate of childhood routine immunization in combination with population 
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characteristics, the study highlighted deficiencies in EPI services and program 
performance. The findings suggested that in addition to governmental involvement and 
leadership, multifaceted approaches to interventions are imperative to improve 
immunization coverage in both Rwanda and Uganda. Without a systematic multilevel 
approach to interventions, ineffective EPI services will persist and vaccination coverage 
will remain low.  
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Figure 1. Map of Africa highlighting Rwanda and Uganda 
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Figure 2. Country Comparison: Rwanda & Uganda 
Source: CIA FactBook http://www.indexmundi.com/factbook/compare/rwanda.uganda 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Characteristics   
Geography Rwanda Uganda 
Location Central Africa, east of 
Democratic Republic of the 
Congo 
East-Central Africa, west of 
Kenya, east of the Democratic 
Republic of the Congo 
Climate Temperate Tropical  
Demographics   
Population  
Age Structure  
0-14 years  
Total Median Age 
12,012,589 (2013 est.) 34,758,809 (2013 est.) 
42.3% 48.9% 
 
18.7 years 
 
15.5 years 
Birth Rate 35.49 births/1,000 population 
(2013 est.) 
44.5 births/1,000 population 
(2013 est.) 
Total Infant Mortality 61.03 deaths/1,000 live births 
(2013 est.) 
62.47 deaths/1,000 live births 
(2013 est.) 
Total Life Expectancy  58.85 years 53.98 years 
Urban population 19.1% of total population (2011) 15.6% of total population 
(2011) 
Education Expenditures 4.8% of GDP (2011) 3.3% of GDP (2012) 
Health Expenditures 10.8% of GDP (2011) 9.5% of GDP (2011) 
Hospital Bed Density  1.6 beds/1,000 population (2007) 0.5 beds/1,000 population 
(2010) 
Government   
Government type Republic Republic 
Economy   
GDP per capita (2012) $1,500 (2012 est.) $1,400 (2012 est.) 
Population below poverty line 44.9% (2011 est.) 24.5% (2009 est.) 
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Table 1 Demographic and Background Characteristics of Sample by Countries 
(N=16880): RDHS 2010 and UDHS 2011 Individual	  	  Characteristics	   Rwanda	  N	  =	  9002	  (%)	   Uganda	  N	  =	  7878	  (%)	  
Sex	  of	  Child	   	   	  Female	   4416	  (49.1)	   3934	  (49.9)	  Male	   4586	  (50.9)	   3944	  (50.1)	  
Age	  of	  Child	  in	  months	  (N=6347)	   	   	  <12	   858	  (20.8)	   543	  (24.5)	  12-­‐23	   722	  (17.5)	   451	  (20.4)	  24-­‐35	   885	  (21.4)	   417	  (18.8)	  36-­‐47	   838	  (20.3)	   421	  (17.3)	  48-­‐49	   830	  (20.1)	   382	  (17.3)	  
Received	  all	  8	  vaccines1	  (N=15776)	   	   	  Yes	   6431	  (75.9)	   3107	  (42.5)	  No	   2040	  (24.1)	   4198	  (57.5)	  
Parents’	  Age	  (N=14851)	   	   	  <20	   52	  (.6)	   75	  (1.1)	  20-­‐34	   4627	  (57.7)	   3700	  (54.1)	  35-­‐49	   3334	  (41.6)	   3036	  (44.8)	  
Parents’	  Education	  (N=16320)	   	   	  No	  Education	   1171	  (13.4)	   797	  (10.5)	  Primary	   6373	  (73.1)	   3979	  (52.3)	  Secondary	  &	  Higher	   1173	  (13.5)	   2827	  (37.2)	  
Wealth	  Index	   	   	  Poorest	   2082	  (23.1)	   2030	  (25.8)	  Poorer	   1904	  (21.2)	   1550	  (19.7)	  Middle	   1767	  (19.6)	   1405	  (17.8)	  Richer	   1649	  (18.3)	   1230	  (15.6)	  Richest	   1600	  (17.8)	   1663	  (21.1)	  
Residence	   	   	  Urban	   1225	  (13.6)	   1682	  (21.4)	  Rural	   7777	  (86.4)	   6196	  (78.6)	  
Insurance	  Coverage	  (N	  =	  9082)	   	   	  Insured	   6594	  (73.3)	   48	  (58.5)	  Uninsured	  	   2406	  (26.7)	   34	  (41.5)	  
1BCG, measles, and three doses of each pentavalent and polio vaccine 
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Table 2 Chi-square analysis assessing the proportion of children that received full immunization (all 
8 EPI vaccines): RDHS 2010 and UDHS 2011 
Individual Characteristics Rwanda Uganda 
No Yes X2 (p-value) No Yes X2 (p-value) 
Sex of Child                      4.950 (.026)                           .083 (.774) 
Female 1048 (51.4) 3122 (48.5)  2107 (50.2) 1570 (50.5)  
Male 992 (48.6) 3309 (51.5)  2091 (49.8) 1537 (49.5)  
Age of Child in months               1576.782 (<. 001)                 290.363 (<. 001) 
<12 650 (65) 207 (6.6)  483 (37.8) 58 (6.3)  
12-23 65 (6.5) 656 (21)  229 (17.9) 220 (23.8)  
24-35 84 (8.4) 801 (25.6)  194 (15.2) 221 (23.9)  
36-47 82 (8.2) 753 (24.1)  195 (15.3) 222 (24)  
48-49 119 (11.9) 708 (22.7)  177 (13.8) 204 (22.1)  
Parents’ Age                   48.977 (<. 001)                   27.614 (<. 001) 
<20 29 (1.6) 21 (.4)  52 (1.4) 12 (.4)  
20-34 1106 (61.3) 3245 (56.5)  2030 (55.9) 1414 (52)  
35-49 670 (37.1) 2473 (43.1)  1550 (42.7) 1292 (47.5)  
Parents’ Education                         4.603 (.100)                   36.537 (<. 001) 
No Education 265 (13.5) 821 (13.1)  473 (11.7) 260 (8.7)  
Primary 1458 (74.3) 4543 (72.8)  2163 (53.5) 1514 (50.4)  
Secondary & Higher 238 (12.1) 876 (14)  1404 (34.8) 1231 (41)  
Wealth Index                   38.278 (<. 001)                   33.009 (<. 001) 
Poorest 518 (25.4) 1420 (22.1)  1161 (27.7) 719 (23.1)  
Poorer 495 (24.3) 1297 (20.2)  836 (19.9) 586 (18.9)  
Middle 386 (18.9) 1277 (19.9)  748 (17.8) 552 (17.8)  
Richer 321 (15.7) 1228 (19.1)  636 (15.2) 509 (16.4)  
Richest 320 (15.7) 1209 (18.8)  817 (19.5) 741 (23.8)  
Residence                   12.773 (<. 001)                   28.176 (<. 001) 
Urban 2311 (11.3) 929 (14.4)  809 (19.3) 759 (24.4)  
Rural 1809 (88.7) 5502 (85.6)  3389 (80.7) 2348 (75.6)  
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Table 3 Adjusted odds ratios and 99% confidence interval for stepwise logistic regression: RDHS 
2010 and UDHS 2011 
 
 	  	  	  	  	  	  	  	  
Individual	  Characteristics	  	   Rwanda	   Uganda	  AOR	  (99%	  CI)	   P	   AOR	  (99%	  CI)	   P	  
Sex	  of	  Child	   	   	   	   	  Female	   .738	  (.579	  –	  .940)	   .001	   .858	  (.673	  –	  1.093)	   .103	  Male	   Ref	   	   Ref	   	  
Age	  of	  Child	  in	  months	   	   	   	   	  <12	   Ref	   	   Ref	   	  12-­‐23	   34.853	  (23.331	  –	  52.064)	   <.	  001	   8.305	  (5.361	  –	  12.864)	   .565	  24-­‐35	   32.938	  (22.756	  –	  47.675)	   <.	  001	   9.986	  (6.404	  –	  15.571)	   .352	  36-­‐47	   30.955	  (21.286	  –	  45.014)	   <.	  001	   9.799	  (6.280	  –	  15.290)	   .096	  48-­‐49	   20.251	  (14.396	  –	  28.487)	   <.	  001	   9.880	  (6.287	  –	  15.524)	   .484	  
Parents’	  Age	   	   	   	   	  <20	   Ref	   	   Ref	   	  20-­‐34	   3.257	  (1.116	  –	  9.503)	   .005	   1.898	  (.523	  –	  6.884)	   .200	  35-­‐49	   2.684	  (.913	  –	  7.892)	   .018	   2.076	  (.570	  –	  7.561)	   .145	  
Parents’	  Education	   	   	   	   	  No	  Education	   Ref	   	   Ref	   	  Primary	   1.226	  (.785	  –	  1.915)	   .238	   1.408	  (.842	  –	  2.356)	   .087	  Secondary	  &	  Higher	   1.624	  (.918	  –	  2.874)	   .029	   1.787	  (1.027	  –	  3.109)	   .007	  
Wealth	  Index	   	   	   	   	  Poorest	   Ref	   	   Ref	   	  Poorer	   1.121	  (.787	  –	  1.595)	   .406	   .919	  (.629	  –	  1.343)	   .565	  Middle	   1.175	  (.814	  –	  1.697)	   .258	   1.150	  (.781	  –	  1.695)	   .352	  Richer	   1.472	  (1.002	  –	  2.164)	   .010	   1.302	  (.865	  –	  1.959)	   .096	  Richest	   1.243	  (.779	  –	  1.985)	   .230	   .877	  (.542	  –	  1.420)	   .484	  
Residence	   	   	   	   	  Urban	   Ref	   	   Ref	   	  Rural	   .644	  (.410	  –	  1.013)	   .012	   .679	  (.460	  –	  1.002)	   .010	  
Nagelkerke R2	   .447	   .207	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Table 4 MCV coverage rate of fully immunized children: RDHS 2010 and UDHS 2011 
	  
 
 
Received Measles vaccine 
Received all 8 EPI vaccines 
Rwanda 
N = 9002 (%) 
Uganda 
N = 7878 (%) 
Yes 6956 (82.1) 5017 (68.4) 
